Injectable Drug Delivery Market
Market Insights on Injectable Drug Delivery covering sales outlook, demand forecast & up-to-date key trends
Injectable Drug Delivery Market By Product (Self-Injectors, Needle-Free Injectors, Auto-Injectors), Usage (Disposable Injectors, Reusable Injectors), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-Commerce) & Region - Forecast 2022 - 2028
Injectable Drug Delivery Market Snapshot (2022-2028)
[232 Pages Report] Sales in the global Injectable Drug Delivery Market are slated to top US$ 41.5 Bn in 2022, projects Future Market Insights (FMI). Expanding at a healthy 8.9% CAGR, the market size is projected to total US$ 69.13 Bn by 2028.
The increasing adoption of self-administrated drugs that require regular doses, favored by cost-effectiveness and reduced hospital visits is boosting sales in the market. In addition to this, the growing preference for smart devices that can track doses and facilitate patient compliance is expected to remain one of the chief drivers of the injectable drug delivery market over the assessment period.
|
Attribute |
Details |
|
Estimated Injectable Drug Delivery Market Size 2022 |
US$ 41.5 Bn |
|
Injectable Drug Delivery Market Value-based CAGR (2022-2028) |
~8.9% |
|
Projected Injectable Drug Delivery Market Size in 2028 |
US$ 69.13 Bn |
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1, 2021 |
8.57% |
|
H1, 2022 Projected |
8.78% |
|
H1, 2022 Outlook |
7.68% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 110 ↓ |
|
BPS Change – H1, 2022 (O) – H1, 2021 |
(-) 89 ↓ |
According to Future Market Insights analysis, the global injectable drug delivery market expects to drop by 89 Basis Point Share (BPS) in H1-2022 as compared to H1- 2021. The requirement for consistency and simplicity of administration for pharmacological combinations is a significant technological problem in the market associated with the observed drop in the BPS values.
The use of injectables is accompanied with a number of clinical difficulties. In comparison to H1-2022 projected value, the market during H1-2022 outlook period will show a dip of 110 BPS.
In addition to managing adverse drug reactions without reserving the possibility to promptly withdraw therapy, these difficulties also include concerns about the possibility of injection site reactions (which may be made worse by the existing requirement for large injection volumes) and the possibility of viral resistance developing during extended periods of sub-therapeutic exposure following therapy discontinuation.
The increasing adoption of self-administrated drugs that require regular doses, favoured by cost-effectiveness and reduced hospital visits is boosting sales in the market. In addition to this, the growing preference for smart devices that can track doses and facilitate patient compliance is expected to remain one of the chief drivers of the injectable drug delivery market over the assessment period.
2022-2028 Injectable Drug Delivery Market Outlook in Comparison to Growth Registered in 2014-2021
Demand for injectable drug delivery is poised to grow at a robust 8.9% CAGR, in comparison with the 7.2% CAGR registered between 2014 and 2021.
Burgeoning demand for cost-effective and quality drug injectors is encouraging product development in the market. The COVID-19 outbreak has spurred awareness regarding hygienic and safe injectors, which is compelling several manufacturers to launch sterile injectables, auto-injectors drug delivery devices, and wearables.
Injectable devices primarily find applications in the treatment of diabetes. As per the World Health Organization (WHO), diabetes incidence rose from 108 million in 1980 to 422 million in 2014. In 2019, diabetes was the ninth leading cause of death, with approximately 1.5 million deaths directly caused by the disease.
Diabetes patients are prescribed insulin which requires regular administration. On the flip side, the risk of needle-stick injuries is a common concern. Hence, injectable drug delivery and wearable insulin pumps are emerging as the most preferred options for diabetic patients. These devices have thin needles that eliminate the risk of injuries.
The introduction of smart wearables and devices that track time and dosage will continue boosting sales in the injectable drug delivery technology market. These devices send timely reminders and offer automatic dose adjustment to facilitate treatment adherence and compliance.
How is the Development of Novel Drugs Fast-tracking Growth in Injectable Drug Delivery Market?
Rinsing incidence of chronic ailments and other life-threatening diseases is underpinning the need for novel and effective drugs in various therapeutic areas. The convenience and at-home accessibility offered by injectable drugs are compelling manufacturers and pharmaceutical companies to develop efficient devices for the treatment of various ailments.
For instance, the use of injectable contraceptives has been increasing considerably since the last few years. This can be attributed to the high efficacy and convenience offered by these injectables. These contraceptives are not required to be taken daily, they can be administered once a month or three months. Due to this factor, sales of these injectable drug delivery devices are gaining traction.
Coupled with this, timely drug approvals by regulatory bodies such as the Food and Drug Administration (FDA) and the Medicines and Healthcare Products Regulatory Agency (MHRA) will widen the scope for the adoption of injectable drug delivery.
In January 2021, the FDA announced the approval of Cabenuva (cabotegravir and riprivine) in injectable formulation as a complete treatment regimen for human immunodeficiency virus type-1 (HIV-1) infection in adults. This is the first FDA-approved injectable which requires to be administered once a month.
Collaborations among pharmaceutical companions and research organizations for drug research and development are also expected to bode well for the market. In February 2021, for instance, Phillips Medisize and Subcuject announced a collaboration to launch a new wearable bolus injector.
Its simple osmotic drive offers low-cost bolus injection technology, allowing injectable wearable devices to be applied in a broader range of drugs. The new product meets the growing demand for large volume injectors to reduce injection frequency, and supports at-home medication delivery. Backed by such developments, the needle-free injectors market is expected to witness considerable growth in the forthcoming years.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCountry-wise Insights
How is the U.S. Injectable Drug Delivery Market Faring?
“Increasing Cases of Cancer to Boost the Development of Injectable Drug Delivery Devices”
The rising incidence of chronic diseases, such as cancer and diabetes in the U.S. is anticipated to spur the demand for smart and effective drug delivery options for better treatment. This is likely to usher new product developments by manufacturers and research institutes in the country, thereby boosting the growth. As per FMI, the North America market is projected to account for 33.4% of the total market share in 2021.
As per the National Cancer Institute, an estimated 1,806,590 new cases of cancer were diagnosed in the U.S. in 2020. This is expected to propel the development of novel injectable drug delivery devices in the oncology sector, thereby augmenting the growth of the U.S. market.
The presence of a robust healthcare sector, public healthcare reimbursements, and delivery of medical devices and medications through online channels will also continue to augment the U.S. market in the forthcoming years.
What is the U.K. Injectable Drug Delivery Market Outlook?
“Technological Development of Auto-injectors Drug Delivery to Propel the Growth”
Growing demand for smart and effective wearables for patient care in the U.K. is expected to boost sales over the assessment period. The Europe injectable drug delivery market is forecast to command 29.4% of the global market share in 2021, finds FMI.
Ongoing technological advancements in self-injection devices, especially in auto-injectors drug delivery and wearables for the administration of large volume and high-viscosity drugs are creating lucrative opportunities for market players in the U.K. This is expected to continue fueling the growth of the market.
Apart from that, the introduction of connective technology, such as Artificial Intelligence (AI) and Bluetooth in smart wearables is expected to bode well for the U.K. market. These devices send alerts regarding dosage timings and track dosages, thereby making them an effective drug delivery method for the elderly.
Why is the China Injectable Drug Delivery Market Witnessing High Demand?
“Availability of Low-cost Raw Materials to Push the Sales of Self-injection Devices”
China is expected to account for a dominant share in the East Asia market over the forecast period. As per FMI, East Asia is expected to account for 14.4% of the total market share in 2021.
Increasing investments in the expansion of the healthcare sector by government bodies in China are creating a conducive environment for novel drug development in the country. Various global pharmaceutical companies are aiming to expand their footprints in China, owing to the wide availability of low-cost raw materials and growing demand for branded drugs, as well as self-injection devices.
Further, the expansion of the biologics sector will continue pushing sales in the market. Increasing production of vaccines, insulin, gene and cellular therapies, growth inhibitors, and cytokines in the biologics sector is spurring the demand for effective drug delivery options, which in turn, is augmenting the growth of the market in China.
Category-wise Insights
Why are Needle-free Injectors Highly Sought-After?
“Need to Eliminate Possible Injuries and Pain to Propel the Needle-free Injectors Market”
Based on product type, the demand for needle-free injectors is expected to gain traction in the forthcoming years, as per the report. Needle-free injectors eliminate pain and possible injuries as they drive drugs through the patients’ skin using any of the forces such as Shock Wave, Lorenz, and electrophoresis, which nullifies the need for hypodermic needles.
Needle-free Injection Technology (NFIT) is a beneficial development in the pharmaceutical industry as it is highly useful in mass vaccination and immunization programs, thereby eliminating the chances of needle injuries and multiple use of single needle. Backed by these factors, the needle-free injectors market is anticipated to grow at a fast pace over the forecast period.
Why is the Demand for Reusable Injectors Rising?
“Ability of Auto-injectors Drug Delivery Devices to Surge Therapeutic Value Will Boost Demand for Reusable Injectors”
In terms of usage, sales of reusable injectors are projected to gain traction over the assessment period. Biological and biosimilar drugs are fragile proteins, which require administration through injection. Auto-injectors drug delivery devices increases the therapeutic value of these drugs, which is propelling the sales of reusable injectors.
When these drugs are prescribed to patients with chronic diseases, such as growth hormone disorders, multiple sclerosis, and diabetes, reusable injectors are a sensible option for administering daily doses. These injectors improve safety and accessibility while reducing the volume of storage and waste footprint, and are significantly more cost-effective.
Which is the Most Preferred Distribution Channel?
“Hospital Pharmacies to Exhibit High Sales of Pen-injectors Drug Delivery Products”
Demand in the hospital pharmacies segment is projected to gain momentum over the forecast period, owing to the assistance offered by healthcare providers regarding the usage of injectables. Besides this, wide availability of products, such as pen-injectors drug delivery devices at these pharmacies will continue boosting sales in this segment.
However, the e-commerce segment is projected to expand at a considerable pace. This growth is attributable to the high emphasis on safety and no-contact delivery induced by the COVID-19 pandemic. The surging availability of drugs and medical equipment on online retail channels and timely delivery offered by them is a chief factor driving sales in this segment.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Competition Landscape
Leading players operating in the global injectable drug delivery market are focusing on research and development activities to launch innovative products in the market. In addition to this, these players are investing in mergers, acquisitions, and collaborations to gain a competitive edge in the injectable drug delivery technology market. For instance:
- In September 2021, Antares Pharma, Inc. announced that it has begun the phase 1 study for ATRS-1902 for adrenal crisis rescue. The program supports a proposed indication for treatment of acute adrenal insufficiency in adults and adolescents, using a new proprietary auto-injector platform to deliver a liquid formulation of hydrocortisone.
- In November 2021, Becton, Dickinson and Company launched the BD Ultrasafe Plus 2.25 ml Passive Needle Guard for use in drug-device combination products. When combined with Glass Prefillable Syringe, the new system enables delivery of biologic solutions of different volumes up to 2ml and viscosities of up to 30 cP.
Injectable Drug Delivery Market Report Scope
Future Market Insights’ latest report sheds light into the factors that are driving sales of injectable drug delivery products and devices. For instance, how are increasing prevalence of diabetes and the rising adoption of injectable contraceptives augmenting the demand for injectable drug delivery technology, have been thoroughly analyzed.
Future Market Insights has conducted meticulous research to unveil major investment pockets within the injectable drug delivery industry. It brings leading distribution channels among hospital pharmacies, retail pharmacies, and e-commerce under the spotlight.
The report highlights why needle-free injectors are scoring high in terms of consumer preference. Apart from that, it presents exhaustive research into various factors pushing reusable injectors to the forefront.
The report further offers a geographic assessment that consists of in-depth information about latest trends that are accelerating both developed and developing economies. It identifies why the rising incidence of cancer in the U.S. is catapulting North America injectable drug delivery market to the dominant position.
Besides, the report delivers a few chapters on recent industry developments in terms of injectable drug delivery innovations. The overall impact of these developments have been scrutinized to offer a unique outlook for 2022-2028.
The injectable drug delivery market analysis includes:
- A 6-year realistic outlook of injectable drug delivery sales forecast across 7 verticals
- Insights into current trends, growth drivers, and new opportunities
- Go-to-market strategies and elaborate information to identify customers for potential opportunities
- Insights into geographic opportunities that have the highest market potential and unmet needs
- Statistics and graphs to evaluate new revenue sources and target customers
|
Attribute |
Details |
|
Forecast Period |
2022-2028 |
|
Historical Data Available for |
2014-2021 |
|
Market Analysis |
Units for Volume and US$ Mn for Value |
|
Report Coverage |
Market forecast, company share analysis, competition intelligence, DROT analysis, market dynamics and challenges, and strategic growth initiatives |
|
Key Segments Covered |
|
|
Key Regions Covered |
|
|
Key Companies Profiled |
Amgen Inc., Antares Pharma Inc., Becton, Dickinson and Company, Consort Medical Plc (Bespak), Crossjet, Medtronic plc, Mylan N.V., SHL Group, West Pharmaceutical Services, and Ypsomed. |
|
Customization & Pricing |
Available upon Request |
Injectable Drug Delivery Market by Category
Product Type:
- Self-Injectors
- Needle-free Injectors
- Auto-Injectors
Usage:
- Disposable Injectors
- Reusable Injectors
Distribution Channels:
- Hospital Pharmacies
- Retail Pharmacies
- E-commerce
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East & Africa
Frequently Asked Questions
The global injectable drug delivery market is expected to reach a valuation of US$ 41,1501.1 Mn in 2022.
The global injectable drug delivery market grew at a healthy 7.2% CAGR between 2014 and 2021.
Increasing demand for self-administrated drugs, along with growing demand for smart wearables are chief factors driving sales of injectable drug delivery.
Amgen Inc., Antares Pharma Inc., Becton, Dickinson and Company, Consort Medical Plc (Bespak), Crossjet, Medtronic plc, Mylan N.V., SHL Group, West Pharmaceutical Services, and Ypsomed are some of the leading players operating in the global injectable drug delivery market.
North America injectable drug delivery market is projected to account for 33.4% of the total market share in 2021.
The injectable drug delivery market in Europe is anticipated to account for 29.4% of the total market share over the assessment period.
Table of Content
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Market Background
4.1. Recent Developments
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
5. Global Economic Outlook
5.1. Gross Domestic Product by Region & Country, 2006 – 2021
6. Key Inclusions
6.1. Key Manufacturer List
6.2. Key Developments
6.3. PEST Analysis
7. North America Market Analysis 2014–2021 and Forecast 2022–2028
7.1. Introduction
7.2. Regional Market Trends
7.3. Historical Market Size (US$ Mn) Analysis By Country, 2014–2021
7.3.1. U.S.
7.3.2. Canada
7.4. Market Size (US$ Mn) Forecast By Country, 2022–2028
7.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2014–2021
7.5.1. Self-Injectors
7.5.2. Needle free Injectors
7.5.2.1. Pre Filled Needle free injectors
7.5.2.2. Fill-Able Needle Free Injectors
7.5.3. Auto Injectors
7.6. Market Size (US$ Mn) Forecast By Product Type, 2022–2028
7.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2014–2021
7.7.2. Reusable Injectors
7.7.2. Reusable Injectors
7.8. Market Size (US$ Mn) Forecast By Usage Type, 2022–2028
7.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2014–2021
7.9.1. Retail Pharmacies
7.9.2. Hospital pharmacies
7.9.3. E-Commerce
7.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2022–2028
7.11. Drivers and Restraints: Impact Analysis
7.12. Market Attractiveness Analysis
7.12.1. By Country
7.12.2. By Product
7.12.3. By Usage
7.12.4. By Distribution Channel
7.13.Drivers and Restraints – Impact Analysis
8. Eastern Europe Market Analysis 2014–2021 and Forecast 2022–2028
8.1. Introduction
8.2. Regional Market Trends
8.3. Historical Market Size (US$ Mn) By Country, 2014–2021
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Spain
8.3.5. Italy
8.3.6. Rest of Western Europe
8.4. Market Size (US$ Mn) Forecast By Country, 2022–2028
8.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2014–2021
8.5.1. Self-Injectors
8.5.2. Needle free Injectors
8.5.2.1. Pre Filled Needle free injectors
8.5.2.2. Fill-Able Needle Free Injectors
8.5.3. Auto Injectors
8.6. Market Size (US$ Mn) Forecast By Product Type, 2022–2028
8.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2014–2021
8.7.1. Disposable Injectors
8.7.2. Reusable Injectors
8.8. Market Size (US$ Mn) Forecast By Usage Type, 2022–2028
8.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2014–2021
8.9.1. Retail Pharmacies
8.9.2. Hospital pharmacies
8.9.3. E-Commerce
8.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2022–2028
8.11. Drivers and Restraints: Impact Analysis
8.12. Market Attractiveness Analysis
8.12.1. By Country
8.12.2. By Product
8.12.3. By Usage
8.12.4. By Distribution Channel
8.13. Drivers and Restraints – Impact Analysis
9. Western Europe Market Analysis 2014–2021 and Forecast 2022–2028
9.1. Introduction
9.2. Regional Market Trends
9.3. Historical Market Size (US$ Mn) By Country, 2014–2021
9.3.1. Russia
9.3.2. Poland
9.3.3. Rest of Eastern Europe
9.4. Market Size (US$ Mn) Forecast By Country, 2022–2028
9.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2014–2021
9.5.1. Self-Injectors
9.5.2. Needle free Injectors
9.5.2.1. Pre Filled Needle free injectors
9.5.2.2. Fill-Able Needle Free Injectors
9.5.3. Auto Injectors
9.6. Market Size (US$ Mn) Forecast By Product Type, 2022–2028
9.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2014–2021
9.7.1. Disposable Injectors
9.7.2. Reusable Injectors
9.8. Market Size (US$ Mn) Forecast By Usage Type, 2022–2028
9.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2014–2021
9.9.1. Retail Pharmacies
9.9.2. Hospital pharmacies
9.9.3. E-Commerce
9.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2022–2028
9.11. Drivers and Restraints: Impact Analysis
9.12. Market Attractiveness Analysis
9.12.1. By Country
9.12.2. By Product
9.12.3. By Usage
9.12.4. By Distribution Channel
9.13. Drivers and Restraints – Impact Analysis
10. Latin America Market Analysis 2014–2021 and Forecast 2022–2028
10.1. Introduction
10.2. Regional Market Trends
10.3. Historical Market Size (US$ Mn) By Country, 2014–2021
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Market Size (US$ Mn) Forecast By Country, 2022–2028
10.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2014–2021
10.5.1. Self-Injectors
10.5.2. Needle free Injectors
10.5.2.1. Pre Filled Needle free injectors
10.5.2.2. Fill-Able Needle Free Injectors
10.5.3. Auto Injectors
10.6. Market Size (US$ Mn) Forecast By Product Type, 2022–2028
10.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2014–2021
10.7.1. Disposable Injectors
10.7.2. Reusable Injectors
10.8. Market Size (US$ Mn) Forecast By Usage Type, 2022–2028
10.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2014–2021
10.9.1. Retail Pharmacies
10.9.2. Hospital pharmacies
10.9.3. E-Commerce
10.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2022–2028
10.11. Drivers and Restraints: Impact Analysis
10.12. Market Attractiveness Analysis
10.12.1. By Country
10.12.2. By Product
10.12.3. By Usage
10.12.4. By Distribution Channel
10.13. Drivers and Restraints – Impact Analysis
11. Asia Pacific excluding Japan and China (APEJC) Market Analysis 2014–2021 and Forecast 2022–2028
11.1. Introduction
11.2. Regional Market Trends
11.3. Historical Market Size (US$ Mn) By Country, 2014–2021
11.3.1. India
11.3.2. Australia and New Zealand
11.3.3. China
11.3.4. ASEAN
11.3.5. Rest of APEJ
11.4. Market Size (US$ Mn) Forecast By Country, 2022–2028
11.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2014–2021
11.5.1. Self-Injectors
11.5.2. Needle free Injectors
11.5.2.1. Pre Filled Needle free injectors
11.5.2.2. Fill-Able Needle Free Injectors
11.5.3. Auto Injectors
11.6. Market Size (US$ Mn) Forecast By Product Type, 2022–2028
11.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2014–2021
11.7.1. Disposable Injectors
11.7.2. Reusable Injectors
11.8. Market Size (US$ Mn) Forecast By Usage Type, 2022–2028
11.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2014–2021
11.9.1. Retail Pharmacies
11.9.2. Hospital pharmacies
11.9.3. E-Commerce
11.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2022–2028
11.11. Drivers and Restraints: Impact Analysis
11.12. Market Attractiveness Analysis
11.12.1. By Country
11.12.2. By Product
11.12.3. By Usage
11.12.4. By Distribution Channel
11.13. Drivers and Restraints – Impact Analysis
12. Japan Market Analysis 2014–2021 and Forecast 2022–2028
12.1. Introduction
12.2. Market Trends
12.4. Market Size (US$ Mn) Forecast By Country, 2022–2028
12.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2014–2021
12.5.1. Self-Injectors
12.5.2. Needle free Injectors
12.5.2.1. Pre Filled Needle free injectors
12.5.2.2. Fill-Able Needle Free Injectors
12.5.3. Auto Injectors
12.6. Market Size (US$ Mn) Forecast By Product Type, 2022–2028
12.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2014–2021
12.7.1. Disposable Injectors
12.7.2. Reusable Injectors
12.8. Market Size (US$ Mn) Forecast By Usage Type, 2022–2028
12.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2014–2021
12.9.1. Retail Pharmacies
12.9.2. Hospital pharmacies
12.9.3. E-Commerce
12.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2022–2028
12.11. Drivers and Restraints: Impact Analysis
12.12. Market Attractiveness Analysis
12.12.1. By Product
12.12.2. By Usage
12.12.3. By Distribution Channel
12.13. Drivers and Restraints – Impact Analysis
13. MEA Market Analysis 2014–2021 and Forecast 2022–2028
13.1. Introduction
13.2. Regional Market Trends
13.3. Historical Market Size (US$ Mn) By Country, 2014–2021
13.3.1. GCC Countries
13.3.2. South Africa
13.3.3. Rest of MEA
13.4. Market Size (US$ Mn) Forecast By Country, 2022–2028
13.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2014–2021
13.5.1. Self-Injectors
13.5.2. Needle free Injectors
13.5.2.1. Pre Filled Needle free injectors
13.5.2.2. Fill-Able Needle Free Injectors
13.5.3. Auto Injectors
13.6. Market Size (US$ Mn) Forecast By Product Type, 2022–2028
13.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2014–2021
13.7.1. Disposable Injectors
13.7.2. Reusable Injectors
13.8. Market Size (US$ Mn) Forecast By Usage Type, 2022–2028
13.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2014–2021
13.9.1. Retail Pharmacies
13.9.2. Hospital pharmacies
13.9.3. E-Commerce
13.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2022–2028
13.11. Drivers and Restraints: Impact Analysis
13.12. Market Attractiveness Analysis
13.12.1. By Country
13.12.2. By Product
13.12.3. By Usage
13.12.4. By Distribution Channel
13.13. Drivers and Restraints – Impact Analysis
14. Forecast Factors: Relevance and Impact
15. Forecast Assumptions
16. Competition Analysis
16.1. Competition Dashboard
16.2. Market Share & Structure Analysis
16.3. Company Deep Dive
16.3.1. Amgen Inc.
16.3.1.1. Overview
16.3.1.2. Product and Usage Portfolio
16.3.1.3. Production Footprint
16.3.1.4. Sales Footprint
16.3.1.5. Channel Footprint
16.3.1.6. Strategy
16.3.1.6.1. Marketing Strategy
16.3.1.6.2. Product Strategy
16.3.1.6.3. Channel Strategy
16.3.2. Antares Pharma Inc.
16.3.2.1. Overview
16.3.2.2. Product and Usage Portfolio
16.3.2.3. Production Footprint
16.3.2.4. Sales Footprint
16.3.2.5. Channel Footprint
16.3.2.6. Strategy
16.3.2.6.1. Marketing Strategy
16.3.2.6.2. Product Strategy
16.3.2.6.3. Channel Strategy
16.3.3. Becton, Dickinson and Company
16.3.3.1. Overview
16.3.3.2. Product and Usage Portfolio
16.3.3.3. Production Footprint
16.3.3.4. Sales Footprint
16.3.3.5. Channel Footprint
16.3.3.6. Strategy
16.3.3.6.1. Marketing Strategy
16.3.3.6.2. Product Strategy
16.3.3.6.3. Channel Strategy
16.3.4. Consort Medical Plc (Bespak)
16.3.4.1. Overview
16.3.4.2. Product and Usage Portfolio
16.3.4.3. Production Footprint
16.3.4.4. Sales Footprint
16.3.4.5. Channel Footprint
16.3.4.6. Strategy
16.3.4.6.1. Marketing Strategy
16.3.4.6.2. Product Strategy
16.3.4.6.3. Channel Strategy
16.3.5. Crossjet
16.3.5.1. Overview
16.3.5.2. Product and Usage Portfolio
16.3.5.3. Production Footprint
16.3.5.4. Sales Footprint
16.3.5.5. Channel Footprint
16.3.5.6. Strategy
16.3.5.6.1. Marketing Strategy
16.3.5.6.2. Product Strategy
16.3.5.6.3. Channel Strategy
16.3.6. Medtronic plc
16.3.6. Overview
16.3.6.2. Product and Usage Portfolio
16.3.6.3. Production Footprint
16.3.6.4. Sales Footprint
16.3.6.5. Channel Footprint
16.3.6.6. Strategy
16.3.6.6.1. Marketing Strategy
16.3.6.6.2. Product Strategy
16.3.6.6.3. Channel Strategy
16.3.7. Mylan N.V.
16.3.7.1. Overview
16.3.7.2. Product and Usage Portfolio
16.3.7.3. Production Footprint
16.3.7.4. Sales Footprint
16.3.7.5. Channel Footprint
16.3.7.6. Strategy
16.3.7.6.1. Marketing Strategy
16.3.7.6.2. Product Strategy
16.3.7.6.3. Channel Strategy
16.3.8. SHL Group
16.3.8.1. Overview
16.3.8.2. Product and Usage Portfolio
16.3.8.3. Production Footprint
16.3.8.4. Sales Footprint
16.3.8.5. Channel Footprint
16.3.8.6. Strategy
16.3.8.6.1. Marketing Strategy
16.3.8.6.2. Product Strategy
16.3.8.6.3. Channel Strategy
16.3.9. West Pharmaceutical Services
16.3.9.1. Overview
16.3.9.2. Product and Usage Portfolio
16.3.9.3. Production Footprint
16.3.9.4. Sales Footprint
16.3.9.5. Channel Footprint
16.3.9.6. Strategy
16.3.9.6.1. Marketing Strategy
16.3.9.6.2. Product Strategy
16.3.9.6.3. Channel Strategy
16.3.10. Ypsomed
16.3.10.1. Overview
16.3.10.2. Product and Usage Portfolio
16.3.10.3. Production Footprint
16.3.10.4. Sales Footprint
16.3.10.5. Channel Footprint
16.3.10.6. Strategy
16.3.10.6.1. Marketing Strategy
16.3.10.6.2. Product Strategy
16.3.10.6.3. Channel Strategy
17. Global Market Analysis 2014–2021 and Forecast 2022–2028, By Region
17.1. Introduction / Key Findings
17.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2014–2021
17.2.1. North America
17.2.2. Western Europe
17.2.3. Eastern Europe
17.2.4. Latin America
17.2.5. Asia Pacific excluding Japan
17.2.6. Japan
17.2.7. Middle East and Africa
17.3. Market Size (US$ Mn) Forecast By Region, 2022–2028
17.4.Market Attractiveness Analysis By Region
18. Global Market Analysis 2014–2021 and Forecast 2022–2028, By Product
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2014–2021
18.2.1. Self-Injectors
18.2.2. Needle-free Injectors
18.2.3. Auto-Injectors
18.3. Market Size (US$ Mn) Forecast By Product Type, 2022–2028
18.4. Market Attractiveness Analysis By Product Type
19. Global Market Analysis 2014–2021 and Forecast 2022–2028, By Usage
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2014–2021
19.2.1. Disposable Injectors
19.2.2. Reusable Injectors
19.3. Market Size (US$ Mn) Forecast By Usage, 2022–2028
19.4. Market Attractiveness Analysis By Usage
20. Global Market Analysis 2014–2021 and Forecast 2022–2028, By Distribution Channel
20.1. Introduction
20.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2014–2021
20.2.1. Retail Pharmacies
20.2.2. Hospital Pharmacies
20.2.3. E-commerce
20.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2022–2028
20.4. Market Attractiveness Analysis By Distribution Channel
21. Global Market Analysis 2014–2021 and Forecast 2022–2028
21.1. Market Value Share Analysis
21.1.1. By Country
21.1.2. By Product
21.1.3. By Usage
21.1.5. By Distribution Channel
21.2.Y-o-Y Growth Analysis
21.2.1. By Country
21.2.2. By Product
21.2.3. By Usage
21.2.5. By Distribution Channel
21.3. Absolute $ Opportunity
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Manufacturers of Market
Table 02: Global Manufacturers of Market
Table 03: North America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Country
Table 04: North America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Product Type
Table 05: North America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Usage
Table 06: North America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Distribution Channel
Table 07: Eastern Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Country
Table 08: Eastern Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Product Type
Table 09: Eastern Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Usage
Table 10: Eastern Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Distribution Channel
Table 11: Western Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Country
Table 12: Western Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Product Type
Table 13: Western Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Usage
Table 14: Western Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Distribution Channel
Table 15: Latin America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Country
Table 16: Latin America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Product Type
Table 17: Latin America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Usage
Table 18: Latin America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Distribution Channel
Table 19: APEJ Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Country
Table 20: APEJ Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Product Type
Table 21: APEJ Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Usage
Table 22: APEJ Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Distribution Channel
Table 23: Japan Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Product Type
Table 24: Japan Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Usage
Table 25: Japan Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Distribution Channel
Table 26: MEA Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Country
Table 27: MEA Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Product Type
Table 28: MEA Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Usage
Table 29: MEA Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Distribution Channel
Table 30: Global Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Region
Table 31: Global Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Product Type
Table 32: MEA Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Usage
Table 33: Global Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Distribution Channel
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Market Share by Product Type (2017A)
Figure 02: Global Market Share by Usage (2017A)
Figure 03: Global Market Share by Distribution Channel (2017A)
Figure 04: Global Market Share by Region (2017A)
Figure 05: Global Healthcare Expenditure in US$ Mn (2014–2020)
Figure 06: North America Market Size
Figure 07: North America Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2026
Figure 08: U.S. Market Size (US$ Mn) Analysis, 2014–2021
Figure 09: U.S. Ambulance Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 10: Canada Market Size (US$ Mn) Analysis, 2014–2021
Figure 11: Canada Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 12: North America Self-injectors Market Size (US$ Mn) Analysis, 2014–2021
Figure 13: North America Self-injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 14: North America Needle-free Injectors Market Size (US$ Mn) Analysis, 2014–2021
Figure 15: North America Needle-free Injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 16: North America Auto injectors Market Size (US$ Mn) Analysis, 2014–2021
Figure 17: North America Auto injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 18: North America Market Attractiveness Analysis, By Country
Figure 19: North America Market Attractiveness Analysis, By Product Type
Figure 20: North America Market Attractiveness Analysis, By Usage
Figure 21: North America Market Attractiveness Analysis, By Distribution Channel
Figure 22: Eastern Europe Market Size
Figure 23: Eastern Europe Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2026
Figure 24: Russia Market Size (US$ Mn) Analysis, 2014–2021
Figure 25: Russia Ambulance Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 26: Poland Market Size (US$ Mn) Analysis, 2014–2021
Figure 27: Poland Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 28: Rest of Eastern Europe Market Size (US$ Mn) Analysis, 2014–2021
Figure 29: Rest of Eastern Europe Ambulance Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 30: Eastern Europe Self-injectors Market Size (US$ Mn) Analysis, 2014–2021
Figure 31: Eastern Europe Self-injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 32: Eastern Europe Needle-free Injectors Market Size (US$ Mn) Analysis, 2014–2021
Figure 33: Eastern Europe Needle-free Injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 34: Eastern Europe Autoinjectors Market Size (US$ Mn) Analysis, 2014–2021
Figure 35: Eastern Europe Autoinjectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 36: Eastern Europe Market Attractiveness Analysis, By Country
Figure 37: Eastern Europe Market Attractiveness Analysis, By Product Type
Figure 38: Eastern Europe Market Attractiveness Analysis, By Usage
Figure 39: Eastern Europe Market Attractiveness Analysis, By Distribution Channel
Figure 40: Western Europe Market Size
Figure 41: Western Europe Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2026
Figure 42: Germany Market Size (US$ Mn) Analysis, 2014–2021
Figure 43: Germany Ambulance Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 44: U.K. Market Size (US$ Mn) Analysis, 2014–2021
Figure 45: U.K. Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 46: France Market Size (US$ Mn) Analysis, 2014–2021
Figure 47: France Ambulance Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 48: Italy Market Size (US$ Mn) Analysis, 2014–2021
Figure 49: Italy Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 50: Spain Market Size (US$ Mn) Analysis, 2014–2021
Figure 51: Spain Ambulance Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 52: Rest of Western Europe Market Size (US$ Mn) Analysis, 2014–2021
Figure 53: Rest of Western Europe Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 54: Western Europe Self-injectors Market Size (US$ Mn) Analysis, 2014–2021
Figure 55: Western Europe Self-injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 56: Western Europe Needle-free Market Size (US$ Mn) Analysis, 2014–2021
Figure 57: Western Europe Needle-free Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 58: Western Europe Autoinjectors Market Size (US$ Mn) Analysis, 2014–2021
Figure 59: Western Europe Autoinjectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 60: Western Europe Market Attractiveness Analysis, By Country
Figure 61: Western Europe Market Attractiveness Analysis, By Product Type
Figure 62: Western Europe Market Attractiveness Analysis, By Usage
Figure 63: Western Europe Market Attractiveness Analysis, By Distribution Channel
Figure 64: Latin America Market Size
Figure 65: Latin America Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2026
Figure 66: Brazil Market Size (US$ Mn) Analysis, 2014–2021
Figure 67: Brazil Ambulance Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 68: Mexico Market Size (US$ Mn) Analysis, 2014–2021
Figure 69: Mexico Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 70: Rest of Latin America Market Size (US$ Mn) Analysis, 2014–2021
Figure 71: Rest of Latin America Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 72: Latin America Self-injectors Market Size (US$ Mn) Analysis, 2014–2021
Figure 73: Latin America Self-injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 74: Latin America Needle-free Market Size (US$ Mn) Analysis, 2014–2021
Figure 75: Latin America Needle-free Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 76: Latin America Autoinjectors Market Size (US$ Mn) Analysis, 2014–2021
Figure 77: Latin America Autoinjectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 78: Latin America Market Attractiveness Analysis, By Country
Figure 79: Latin America Market Attractiveness Analysis, By Product Type
Figure 80: Latin America Market Attractiveness Analysis, By Usage
Figure 81: Latin America Market Attractiveness Analysis, By Distribution Channel
Figure 82: APEJ Market Size
Figure 83: APEJ Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2026
Figure 84: India Market Size (US$ Mn) Analysis, 2014–2021
Figure 85: India Ambulance Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 86: Australia & New Zealand Market Size (US$ Mn) Analysis, 2014–2021
Figure 87: Australia & New Zealand Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 88: China Market Size (US$ Mn) Analysis, 2014–2021
Figure 89: China Ambulance Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 90: ASEAN Countries Market Size (US$ Mn) Analysis, 2014–2021
Figure 91: ASEAN Countries Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 92: Rest of APEJ Market Size (US$ Mn) Analysis, 2014–2021
Figure 93: Rest of APEJ Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 94: APEJ Self-injectors Market Size (US$ Mn) Analysis, 2014–2021
Figure 95: APEJ Self-injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 96: APEJ Needle-free Market Size (US$ Mn) Analysis, 2014–2021
Figure 97: APEJ Needle-free Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 98: APEJ Autoinjectors Market Size (US$ Mn) Analysis, 2014–2021
Figure 99: APEJ Autoinjectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 100: APEJ Market Attractiveness Analysis, By Country
Figure 101: APEJ Market Attractiveness Analysis, By Product Type
Figure 102: APEJ Market Attractiveness Analysis, By Usage
Figure 103: APEJ Market Attractiveness Analysis, By Distribution Channel
Figure 104: Japan Market Size
Figure 105: Japan Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 106: Japan Self-injectors Market Size (US$ Mn) Analysis, 2014–2021
Figure 107: Japan Self-injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 108: Japan Needle-free Market Size (US$ Mn) Analysis, 2014–2021
Figure 109: Japan Needle-free Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 110: Japan Autoinjectors Market Size (US$ Mn) Analysis, 2014–2021
Figure 111: Japan Autoinjectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 112: Japan Market Attractiveness Analysis, By Product Type
Figure 113: Japan Market Attractiveness Analysis, By Usage
Figure 114: Japan Market Attractiveness Analysis, By Distribution Channel
Figure 115: MEA Market Size
Figure 116: MEA Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2026
Figure 117: GCC Countries Market Size (US$ Mn) Analysis, 2014–2021
Figure 118: GCC Countries Ambulance Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 119: South Africa Market Size (US$ Mn) Analysis, 2014–2021
Figure 120: South Africa Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 121: Rest of MEA Market Size (US$ Mn) Analysis, 2014–2021
Figure 122: Rest of MEA Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 123: MEA Self-injectors Market Size (US$ Mn) Analysis, 2014–2021
Figure 124: MEA Self-injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 125: MEA Needle-free Market Size (US$ Mn) Analysis, 2014–2021
Figure 126: MEA Needle-free Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 127: MEA Auto-injectors Market Size (US$ Mn) Analysis, 2014–2021
Figure 128: MEA Auto-injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 129: MEA Market Attractiveness Analysis, By Country
Figure 130: MEA Market Attractiveness Analysis, By Product Type
Figure 131: MEA Market Attractiveness Analysis, By Usage
Figure 132: MEA Market Attractiveness Analysis, By Distribution Channel
Figure 133: Global Market Attractiveness Analysis, By Region
Figure 134: Global Market Attractiveness Analysis, By Product Type
Figure 135: Global Market Attractiveness Analysis, By End User
Figure 136: Global Market Attractiveness Analysis, By Distribution Channel
Figure 137: Global Single-Photon Emission Computed Tomography Historical Market Size and Y-o-Y, 2014 - 2021
Figure 138: Global Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 139: Global Market Absolute $ Opportunity, 2014–2028
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
